| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |